Pharmarise Holdings (TSE:2796) Earnings per Share (Diluted) : 円24.85 (TTM As of Feb. 2024)

Pharmarise Holdings Earnings per Share (Diluted) Chart

Pharmarise Holdings Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
Earnings per Share (Diluted)		Get a 7-Day Free Trial					2.24	46.38	34.64	36.29	26.89

Pharmarise Holdings Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Earnings per Share (Diluted)	Get a 7-Day Free Trial															14.43	13.21	9.93	12.78	-11.07

Competitive Comparison of Pharmarise Holdings's Earnings per Share (Diluted)

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmarise Holdings's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's PE Ratio falls into.

Pharmarise Holdings Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Pharmarise Holdings's Earnings Per Share (Diluted) for the fiscal year that ended in May. 2023 is calculated as

Pharmarise Holdings's Earnings Per Share (Diluted) for the quarter that ended in Feb. 2024 is calculated as

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円24.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Pharmarise Holdings  (TSE:2796) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pharmarise Holdings Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmarise Holdings (TSE:2796) Business Description